Journal for ImmunoTherapy of Cancer (Nov 2021)
768 Systemic delivery of a tumor-targeted TLR9 agonist conjugate transforms the tumor immune landscape and induces tumor regression in mice
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2021)